[Therapy of the chronic bronchitis syndrome].
D000403:Airway Resistance / Q000187:drug effects; D000410:Alanine Transaminase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D001794:Blood Pressure / Q000187:drug effects; D001991:Bronchitis / Q000188:drug therapy* / Q000201:enzymology / Q000503:physiopathology / Q000652:urine; D002908:Chronic Disease; D004338:Drug Combinations; D004809:Ephedrine / Q000627:therapeutic use; D006140:Guaifenesin / Q000627:therapeutic use; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D007958:Leukocyte Count; D012129:Respiratory Function Tests; D013411:Sulfadiazine / Q000627:therapeutic use; D014797:Vital Capacity / Q000187:drug effects
D004338:Drug Combinations; D006454:Hemoglobins; D013411:Sulfadiazine; D006140:Guaifenesin; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D004809:Ephedrine
Beitrag zur Therapie des chronischen bronchitischen Syndroms.